Evidence map›Paper›PMID 33586688›Full record

ArticleEndoscopic ultrasound

Utility of a 20G needle with a core trap in EUS-guided fine-needle biopsy for gastric submucosal tumors: A multicentric prospective trial.

Ken Kamata, Akira Kurita, Satoru Yasukawa, Yasutaka Chiba, Hiroko Nebiki, Masanori Asada, Hiroaki Yasuda, Hideyuki Shiomi, Takeshi Ogura, Makoto Takaoka and 6 more

Open access · greenAbstract read
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Fine needle biopsyEndoscopic ultrasound
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 1 country.

Ken KamataDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Higashiosaka, Japan.
Akira KuritaDepartment of Gastroenterology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
Satoru YasukawaDepartment of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto; Department of Diagnostic Pathology, Japanese Red Cross Kyoto Daini Hospital, Osaka, Japan.
Yasutaka ChibaClinical Research Center, Kindai University Hospital, Osakasayama, Japan.
Hiroko NebikiDepartment of Gastroenterology, Osaka City General Hospital, Osaka, Japan.
Masanori AsadaDepartment of Gastroenterology and Hepatology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
Hiroaki YasudaDepartment of Medicine, Division of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hideyuki ShiomiDepartment of Internal Medicine, Division of Gastroenterology, Graduate School of Medicine, Kobe University, Kobe, Japan.
Takeshi OguraSecond Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan.
Makoto TakaokaThird Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
Noriyuki HokiDepartment of Gastroenterology, Bell Land General Hospital, Sakai, Japan.
Reiko AshidaDepartment of Cancer Survey and Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Minoru ShigekawaDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University, Suita, Japan.
Akio YanagisawaDepartment of Surgical Pathology, Kyoto Prefectural University of Medicine; Department of Diagnostic Pathology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Masatoshi KudoDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Higashiosaka, Japan.
Masayuki KitanoSecond Department of Internal Medicine, School of Medicine, Wakayama Medical University, Wakayama, Japan.
Kindai University · JPBerurando General Hospital · JPJapanese Red Cross Society Kyoto Daini Hospital · JPKansai Medical University · JPKindai University Hospital · JPKitano Hospital · JPKobe University · JPKyoto first Red Cross hospital · JPKyoto Prefectural University of Medicine · JPOsaka City General Hospital · JPOsaka Hospital · JPOsaka Medical and Pharmaceutical University · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPOsaka University · JPWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesDifferential diagnosis to estimate the malignant potential of gastric submucosal tumor (g-SMT) is important for decision-making. This study evaluated the use of a 20G needle with a core trap for EUS-guided fine-needle biopsy (EUS-FNB) for g-SMT.

methodsThis multicentric prospective trial was registered in the University Hospital Medical Information Network (UMIN000021410). Consecutive patients with g-SMT who presented at one of the nine Japanese Referral Centers between June 2017 and November 2018 were enrolled. All patients underwent EUS-FNB using a 20G needle with a core trap. Samples obtained with the first-needle pass were used for central pathological review. EUS-FNB was evaluated in terms of (i) technical success rate, (ii) adequacy for histological evaluation, (iii) rate of complications, (iv) accuracy for histological diagnosis of gastrointestinal stromal tumor (GIST), and (v) concordance between GIST mitotic index determined by EUS-FNB and after tumor resection.

resultsThe study included 52 patients. The technical success rate of EUS-FNB was 100%. The adequacy rate for histological evaluation was 90.4% (P < 0.001). There were no complications related to EUS-FNB. Of the 38/52 patients who underwent surgical resection, 36 were finally diagnosed with GIST. The sensitivity, specificity, and accuracy of EUS-FNB for the histological diagnosis of g-SMT were 80.6%, 100%, and 81.6%, respectively. The concordance rate between the mitotic index on EUS-FNB and that after analysis of the resected tumor was 89.7%.

conclusionsEUS-FNB using a 20G needle with a core trap is feasible, providing histological samples of sufficient quality for diagnosing g-SMT.

Indexed as

20G needlecore trapEUS-FNAEUS-guided fine-needle biopsysubmucosal tumor

Identifiers

PMID33586688
PMCPMC8098841
OpenAlexW3126498804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.